Nano-X Imaging crushed expectations on the downside with a 30% revenue miss and a going concern warning, prompting the company to ditch its 2026 guidance and halt periodic financial targets entirely. The medical imaging company burned $13.95 million in operating cash last quarter while cash reserves fell to just $44.2 million, leaving it racing against a shrinking runway to land its Nanox.ARC deployments and fix its commercialization timeline.
Nano-X Imaging :
NNOX
NNOX
Stock Data
$0.86
$0.03 (2.84%)
Asset Type
Common Stock
Exchange
NASDAQ
Currency
USD
Country
USA
Sector
HEALTHCARE
Industry
MEDICAL DEVICES
Nano X Imaging Ltd is revolutionizing the medical imaging industry with its advanced tomographic imaging device, the Nanox.ARC, which utilizes a unique digital X-ray source. This innovation is complemented by Nanox.CLOUD, a comprehensive platform that streamlines the process of matching medical images with radiologists, alongside offering AI-driven diagnostic support, billing, and reporting services. Additionally, the company's marketplace fosters connections between imaging facilities and radiologists, enhancing access to remote interpretations. With a focus on AI-based software for detecting medical conditions and a robust teleradiology service, Nano X Imaging is at the forefront of making cutting-edge medical imaging more accessible and efficient.
Latest Activity
All Nano-X Imaging Articles
0 Articles
No articles found for Nano-X Imaging.